应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02251 鹰瞳科技-B
休市中 05-25 16:08:15
10.680
-0.020
-0.19%
最高
10.940
最低
10.540
成交量
9.76万
今开
10.700
昨收
10.700
日振幅
3.74%
总市值
11.06亿
流通市值
2.77亿
总股本
1.04亿
成交额
105.05万
换手率
0.38%
流通股本
2,593万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
鹰瞳科技-B(02251)建议委任安永会计师事务所为新任核数师
智通财经 · 05-23
鹰瞳科技-B(02251)建议委任安永会计师事务所为新任核数师
鹰瞳科技-B拟1.82亿元收购北京智瞳科技70%股权
新浪港股 · 05-22
鹰瞳科技-B拟1.82亿元收购北京智瞳科技70%股权
鹰瞳科技-B(02251)拟1.82亿元收购北京智瞳科技70%股权
智通财经 · 05-19
鹰瞳科技-B(02251)拟1.82亿元收购北京智瞳科技70%股权
鹰瞳科技-B(02251.HK)拟1.82亿元收购北京智瞳科技70%股权 进一步加强现有产品组合
格隆汇资讯 · 05-19
鹰瞳科技-B(02251.HK)拟1.82亿元收购北京智瞳科技70%股权 进一步加强现有产品组合
鹰瞳科技-B午盘涨超5% 中金首次给予目标价17.40港元
新浪港股 · 05-18
鹰瞳科技-B午盘涨超5% 中金首次给予目标价17.40港元
港股异动 | 鹰瞳科技-B(02251)盘中涨超6% AI医疗迎突破 公司立足AI眼底影像筛查
智通财经 · 05-18
港股异动 | 鹰瞳科技-B(02251)盘中涨超6% AI医疗迎突破 公司立足AI眼底影像筛查
港股概念追踪 | 医疗大模型“Uni-talk”发布 AI医疗迎新突破!受益龙头厂商名单出炉(附概念股)
智通财经 · 05-17
港股概念追踪 | 医疗大模型“Uni-talk”发布 AI医疗迎新突破!受益龙头厂商名单出炉(附概念股)
鹰瞳科技-B盘中异动 临近收盘股价大跌5.26%报10.801港元
自选股智能写手 · 05-17
鹰瞳科技-B盘中异动 临近收盘股价大跌5.26%报10.801港元
一图解码:一脉阳光赴港IPO 第三方医学影像龙头 盈利不佳
财华社 · 05-17
一图解码:一脉阳光赴港IPO 第三方医学影像龙头 盈利不佳
第三方医学影像龙头搞AI,一脉阳光冲刺港交所,三年亏超5亿
格隆汇 · 05-16
第三方医学影像龙头搞AI,一脉阳光冲刺港交所,三年亏超5亿
县城医学影像之王:一脉阳光正奔港交所IPO
华尔街见闻 · 05-13
县城医学影像之王:一脉阳光正奔港交所IPO
【IPO解码】第三方医学影像龙头递表港交所,一脉阳光成色几何
财华社 · 05-12
【IPO解码】第三方医学影像龙头递表港交所,一脉阳光成色几何
中金:首予鹰瞳科技-B(2251.HK)跑赢行业评级 目标价17.4港元
权证网 · 05-12
中金:首予鹰瞳科技-B(2251.HK)跑赢行业评级 目标价17.4港元
鹰瞳科技-B公布H股全流通获联交所授出上市批准
新浪港股 · 05-12
鹰瞳科技-B公布H股全流通获联交所授出上市批准
【新股IPO】江西一脉阳光集团向港交所主板提交上市申请 为医学影像专科医疗集团
凤凰网港股 · 05-11
【新股IPO】江西一脉阳光集团向港交所主板提交上市申请 为医学影像专科医疗集团
鹰瞳科技-B(02251):H股全流通获联交所授出上市批准
智通财经网 · 05-11
鹰瞳科技-B(02251):H股全流通获联交所授出上市批准
鹰瞳科技-B盘中异动 股价大跌5.23%报12.321港元
自选股智能写手 · 05-09
鹰瞳科技-B盘中异动 股价大跌5.23%报12.321港元
鹰瞳科技-B港股跌8.45%
中国经济网 · 05-08
鹰瞳科技-B港股跌8.45%
鹰瞳科技-B盘中异动 下午盘股价大跌5.20%报13.461港元
自选股智能写手 · 05-08
鹰瞳科技-B盘中异动 下午盘股价大跌5.20%报13.461港元
加载更多
公司概况
公司名称:
鹰瞳科技-B
所属市场:
SEHK
上市日期:
--
主营业务:
鹰瞳Airdoc成立于2015年9月,总部在北京,截至2020年1月底,公司在北京、上海、广州、香港设立了子公司及研发中心。 鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者,公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案,通过视网膜影像、多模态数据分析以及人工智能深度学习算法,改善了慢性病传统的早期检测及诊断方式,在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。 2020年8月,鹰瞳Airdoc糖尿病视网膜病变眼底图像辅助诊断软件获国家药监局批准上市,在同类产品中首个获得国家药监局第三类医疗器械证书,并由此展开在国内医院的使用,协助及减轻医生的医学诊断工作。为解决未满足的医疗健康需求,公司开发了人工智能视网膜影像相关的丰富产品管线,已广泛应用于社区诊所、体检中心、保险公司、验光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估
发行价格:
--
{"stockData":{"symbol":"02251","market":"HK","secType":"STK","nameCN":"鹰瞳科技-B","latestPrice":10.68,"timestamp":1685002095015,"preClose":10.7,"halted":0,"volume":97600,"delay":0,"floatShares":25934118,"shares":103568013,"eps":-1.9357495,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"05-25 16:08:15","open":10.7,"high":10.94,"low":10.54,"amount":1050542,"amplitude":0.037383,"askPrice":10.74,"askSize":4000,"bidPrice":10.54,"bidSize":900,"shortable":0,"etf":0,"ttmEps":-1.9357495192812326,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1685323800000},"adr":0,"listingDate":1636041600000,"adjPreClose":10.7,"volumeRatio":0.6796657383982123,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02251","defaultTab":"news","newsList":[{"id":"2337961515","title":"鹰瞳科技-B(02251)建议委任安永会计师事务所为新任核数师","url":"https://stock-news.laohu8.com/highlight/detail?id=2337961515","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2337961515?lang=zh_CN&edition=full","pubTime":"2023-05-23 23:00","pubTimestamp":1684854042,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/934785.html","is_publish_highlight":false},{"id":"2337699118","title":"鹰瞳科技-B拟1.82亿元收购北京智瞳科技70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2337699118","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2337699118?lang=zh_CN&edition=full","pubTime":"2023-05-22 08:48","pubTimestamp":1684716480,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 鹰瞳科技-B(02251)发布公告,于2023年5月19日,公司拟向产业基金收购目标公司(北京智瞳科技有限公司)70%股权,总代价为人民币1.82亿元。\n\n炒股开户享福利,送投顾服务60天体验权,一对一指导服务!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/tob/2023-05-22/doc-imyuraun8450416.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-05-22/doc-imyuraun8450416.shtml","is_publish_highlight":false},{"id":"2336546017","title":"鹰瞳科技-B(02251)拟1.82亿元收购北京智瞳科技70%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2336546017","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336546017?lang=zh_CN&edition=full","pubTime":"2023-05-19 22:55","pubTimestamp":1684508115,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/933274.html","is_publish_highlight":false},{"id":"2336549659","title":"鹰瞳科技-B(02251.HK)拟1.82亿元收购北京智瞳科技70%股权 进一步加强现有产品组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2336549659","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2336549659?lang=zh_CN&edition=full","pubTime":"2023-05-19 22:52","pubTimestamp":1684507948,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051922523383cb4f07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051922523383cb4f07&s=b","is_publish_highlight":false},{"id":"2336237051","title":"鹰瞳科技-B午盘涨超5% 中金首次给予目标价17.40港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336237051","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2336237051?lang=zh_CN&edition=full","pubTime":"2023-05-18 15:30","pubTimestamp":1684395012,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B(02251)午盘上涨5.27%,现报11.58港元,成交额248.090万港元。\n 中金发布研报称,首次覆盖鹰瞳科技-B给予跑赢行业评级,目标价17.40港元,基于PS估值法,对应8.0倍2023年估值。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/tob/2023-05-18/doc-imyuetfy8338367.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-05-18/doc-imyuetfy8338367.shtml","is_publish_highlight":false},{"id":"2336837407","title":"港股异动 | 鹰瞳科技-B(02251)盘中涨超6% AI医疗迎突破 公司立足AI眼底影像筛查","url":"https://stock-news.laohu8.com/highlight/detail?id=2336837407","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336837407?lang=zh_CN&edition=full","pubTime":"2023-05-18 14:33","pubTimestamp":1684391619,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/932195.html","is_publish_highlight":false},{"id":"2336315353","title":"港股概念追踪 | 医疗大模型“Uni-talk”发布 AI医疗迎新突破!受益龙头厂商名单出炉(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2336315353","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2336315353?lang=zh_CN&edition=full","pubTime":"2023-05-17 21:42","pubTimestamp":1684330922,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/932002.html","is_publish_highlight":false},{"id":"2336364847","title":"鹰瞳科技-B盘中异动 临近收盘股价大跌5.26%报10.801港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2336364847","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2336364847?lang=zh_CN&edition=full","pubTime":"2023-05-17 15:38","pubTimestamp":1684309106,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051715382680658f96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023051715382680658f96&s=b","is_publish_highlight":false},{"id":"2336039355","title":"一图解码:一脉阳光赴港IPO 第三方医学影像龙头 盈利不佳","url":"https://stock-news.laohu8.com/highlight/detail?id=2336039355","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2336039355?lang=zh_CN&edition=full","pubTime":"2023-05-17 10:03","pubTimestamp":1684288989,"startTime":"0","endTime":"0","summary":"5月11日,一脉阳光向港交所递交了招股书,计划在主板挂牌上市;由中信证券担任独家保荐人。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202305_1/eccf09f1-051b-4c59-b9bf-0977e07f69ec.jpg","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202305_1/eccf09f1-051b-4c59-b9bf-0977e07f69ec.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/646435dd53243c2a2d950453","is_publish_highlight":false},{"id":"2335282293","title":"第三方医学影像龙头搞AI,一脉阳光冲刺港交所,三年亏超5亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2335282293","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2335282293?lang=zh_CN&edition=full","pubTime":"2023-05-16 14:41","pubTimestamp":1684219317,"startTime":"0","endTime":"0","summary":"高盛、中金等入股","market":"us","thumbnail":"https://img3.gelonghui.com/cdf57-407a2cc7-ba54-41f4-8377-2cd3d7a6fc9c.jpg","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/cdf57-407a2cc7-ba54-41f4-8377-2cd3d7a6fc9c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/604397","is_publish_highlight":false},{"id":"2335021130","title":"县城医学影像之王:一脉阳光正奔港交所IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2335021130","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2335021130?lang=zh_CN&edition=full","pubTime":"2023-05-13 10:30","pubTimestamp":1683945020,"startTime":"0","endTime":"0","summary":"困境也是机会","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/49d13a2a-dffc-4f3c-a103-cb22a38dbe6e.jpeg?imageView2/1/w/340/h/340","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/49d13a2a-dffc-4f3c-a103-cb22a38dbe6e.jpeg?imageView2/1/w/340/h/340"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3688665","is_publish_highlight":false},{"id":"2334068291","title":"【IPO解码】第三方医学影像龙头递表港交所,一脉阳光成色几何","url":"https://stock-news.laohu8.com/highlight/detail?id=2334068291","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2334068291?lang=zh_CN&edition=full","pubTime":"2023-05-12 14:28","pubTimestamp":1683872881,"startTime":"0","endTime":"0","summary":"于5月11日,江西一脉阳光集团股份有限公司(以下简称“一脉阳光”)向香港资本市场发起了冲刺,拟在港交所主板挂牌上市。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202305_1/0d88ad67-98bb-470f-abbc-b9eb4cd8a31f.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202305_1/0d88ad67-98bb-470f-abbc-b9eb4cd8a31f.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/645ddc7153243c2a2d95042c","is_publish_highlight":false},{"id":"2334372490","title":"中金:首予鹰瞳科技-B(2251.HK)跑赢行业评级 目标价17.4港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334372490","media":"权证网","top":-1,"share":"https://www.laohu8.com/m/news/2334372490?lang=zh_CN&edition=full","pubTime":"2023-05-12 09:38","pubTimestamp":1683855488,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B 商业化鹰飞在即,数字化“AI”护瞳力。首次覆盖鹰瞳科技-B给予跑赢行业评级,目标价17.40港元,基于PS估值法,对应8.0倍2023年估值。截至2021年底,国家药监局已批准约50款AI医疗影像软件产品。我们预计,AI眼底影像筛查作为细分赛道之一,有望辅助多种眼病、慢病筛查。公司核心产品Airdoc-AIFUNDUS(1.0)于2020年8月获得第三类医疗器械证书,商业化定价指引已有6个省市落地,后续仍有多项研发及商业化里程碑值得期待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230512093811820f0e54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230512093811820f0e54&s=b","is_publish_highlight":false},{"id":"2334031002","title":"鹰瞳科技-B公布H股全流通获联交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2334031002","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2334031002?lang=zh_CN&edition=full","pubTime":"2023-05-12 08:26","pubTimestamp":1683851160,"startTime":"0","endTime":"0","summary":"鹰瞳科技-B(02251)发布公告,该公司欣然宣布,其近日接获联交所就2748.29万股H股(转换H股)(相当于根据转换及上市将转换为H股的未上市股份最高数目)上市及买卖的批准。\n\n炒股开户享福利,送投顾服务60天体验权,一对一指导服务!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/tob/2023-05-12/doc-imytnpuk3616353.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2023-05-12/doc-imytnpuk3616353.shtml","is_publish_highlight":false},{"id":"2334709077","title":"【新股IPO】江西一脉阳光集团向港交所主板提交上市申请 为医学影像专科医疗集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2334709077","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2334709077?lang=zh_CN&edition=full","pubTime":"2023-05-11 22:53","pubTimestamp":1683816838,"startTime":"0","endTime":"0","summary":"据港交所5月11日披露,江西一脉阳光集团股份有限公司向港交所主板递交上市申请,中信证券为独家保荐人。据悉,公司是2022年中国最大的医学影像专科医疗集团,根据弗若斯特沙利文的资料,按医学影像中心网点数目、设备数目、执业影像医生数目、日均检查量及患者支付的费用计,公司在中国所有第三方医学影像中心运营商中排名第一。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=c5039dd62860c7cf319be62076973654","is_publish_highlight":false},{"id":"2334270595","title":"鹰瞳科技-B(02251):H股全流通获联交所授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2334270595","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2334270595?lang=zh_CN&edition=full","pubTime":"2023-05-11 21:52","pubTimestamp":1683813147,"startTime":"0","endTime":"0","summary":"智通财经APP讯,鹰瞳科技-B(02251)发布公告,该公司欣然宣布,其近日接获联交所就2748.29万股H股(转换H股)(相当于根据转换及上市将转换为H股的未上市股份最高数目)上市及买卖的批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230511215404820dda0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230511215404820dda0d&s=b","is_publish_highlight":false},{"id":"2334607232","title":"鹰瞳科技-B盘中异动 股价大跌5.23%报12.321港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2334607232","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2334607232?lang=zh_CN&edition=full","pubTime":"2023-05-09 09:54","pubTimestamp":1683597292,"startTime":"0","endTime":"0","summary":"2023年05月09日早盘09时54分,鹰瞳科技-B股票出现波动,股价快速跳水5.23%。截至发稿,该股报12.321港元/股,成交量1.37万股,换手率0.05%,振幅4.46%。资金方面,该股资金流入3762港元,流出12.7762万港元。鹰瞳科技-B股票所在的医疗保健设备行业中,整体跌幅为0.15%。鹰瞳科技-B公司简介:北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230509095452836011be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230509095452836011be&s=b","is_publish_highlight":false},{"id":"2333470283","title":"鹰瞳科技-B港股跌8.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2333470283","media":"中国经济网","top":-1,"share":"https://www.laohu8.com/m/news/2333470283?lang=zh_CN&edition=full","pubTime":"2023-05-08 17:07","pubTimestamp":1683536833,"startTime":"0","endTime":"0","summary":"中国经济网北京5月8日讯鹰瞳科技-B(02251.HK)今日港股收报13.00港元,跌幅8.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305081709428204df33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202305081709428204df33&s=b","is_publish_highlight":false},{"id":"2333403481","title":"鹰瞳科技-B盘中异动 下午盘股价大跌5.20%报13.461港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2333403481","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2333403481?lang=zh_CN&edition=full","pubTime":"2023-05-08 13:17","pubTimestamp":1683523031,"startTime":"0","endTime":"0","summary":"2023年05月08日下午盘13时17分,鹰瞳科技-B股票出现异动,股价大幅下跌5.20%。截至发稿,该股报13.461港元/股,成交量2.28万股,换手率0.09%,振幅4.93%。资金方面,该股资金流入22.863万港元,流出7.9926万港元。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。鹰瞳科技-B股票所在的医疗保健设备行业中,整体跌幅为0.09%。鹰瞳科技-B公司简介:北京鹰瞳科技发展股份有限公司是一家中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050813171182c72d36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023050813171182c72d36&s=b","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0632},{"period":"1month","weight":-0.2361},{"period":"3month","weight":-0.3827},{"period":"6month","weight":-0.2974},{"period":"1year","weight":-0.4034},{"period":"ytd","weight":-0.2458}],"websiteUrl":null,"compareEarnings":[{"period":"1week","weight":-0.0497},{"period":"1month","weight":-0.0444},{"period":"3month","weight":-0.0631},{"period":"6month","weight":0.0668},{"period":"1year","weight":-0.0706},{"period":"ytd","weight":-0.0523}],"name":"鹰瞳科技-B","description":"鹰瞳Airdoc成立于2015年9月,总部在北京,截至2020年1月底,公司在北京、上海、广州、香港设立了子公司及研发中心。\n鹰瞳Airdoc是全球视网膜影像人工智能领域的领导者和先行者,公司基于视网膜影像人工智能识别的早期检测、辅助诊断及健康风险评估解决方案,通过视网膜影像、多模态数据分析以及人工智能深度学习算法,改善了慢性病传统的早期检测及诊断方式,在医疗机构和大健康场景中实现对慢性病的无创、精确、快速、高性价比且大规模的诊断及相关健康风险评估。\n2020年8月,鹰瞳Airdoc糖尿病视网膜病变眼底图像辅助诊断软件获国家药监局批准上市,在同类产品中首个获得国家药监局第三类医疗器械证书,并由此展开在国内医院的使用,协助及减轻医生的医学诊断工作。为解决未满足的医疗健康需求,公司开发了人工智能视网膜影像相关的丰富产品管线,已广泛应用于社区诊所、体检中心、保险公司、验光中心及药房等场所,为用户提供疾病辅助诊断及健康风险评估","exchange":"SEHK","nameEN":"Airdoc","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.13.0","shortVersion":"4.13.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"鹰瞳科技-B,02251,鹰瞳科技-B股票,鹰瞳科技-B股票老虎,鹰瞳科技-B股票老虎国际,鹰瞳科技-B行情,鹰瞳科技-B股票行情,鹰瞳科技-B股价,鹰瞳科技-B股市,鹰瞳科技-B股票价格,鹰瞳科技-B股票交易,鹰瞳科技-B股票购买,鹰瞳科技-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"鹰瞳科技-B(02251)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供鹰瞳科技-B(02251)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}